Z. G. Güç Et Al. , "Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography," Nuclear Medicine Communications , vol.43, no.5, pp.560-567, 2022
Güç, Z. G. Et Al. 2022. Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography. Nuclear Medicine Communications , vol.43, no.5 , 560-567.
Güç, Z. G., Turgut, B., Avcı, A., Cengiz, F., Kalender, M. E., & Alacacıoğlu, A., (2022). Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography. Nuclear Medicine Communications , vol.43, no.5, 560-567.
Güç, Zeynep Et Al. "Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography," Nuclear Medicine Communications , vol.43, no.5, 560-567, 2022
Güç, Zeynep G. Et Al. "Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography." Nuclear Medicine Communications , vol.43, no.5, pp.560-567, 2022
Güç, Z. G. Et Al. (2022) . "Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography." Nuclear Medicine Communications , vol.43, no.5, pp.560-567.
@article{article, author={Zeynep Gülsüm Güç Et Al. }, title={Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: The role of PET/computed tomography}, journal={Nuclear Medicine Communications}, year=2022, pages={560-567} }